Bivalve molluscan shellfish, such as oysters, filter large volumes of water as part of their feeding activities and are able to accumulate and concentrate different types of pathogens, particularly noroviruses, from fecal human pollution. Based on our previous observation of a specific binding of the Norwalk strain (prototype norovirus genogroup I) to the oyster digestive tract through an A-like carbohydrate structure indistinguishable from human blood group A antigen and on the large diversity between strains in terms of carbohydrate-binding specificities, we evaluated the different ligands implicated in attachment to oysters tissues of strains representative of two main genogroups of human norovirus. The GI.1 and GII.4 strains differed in that the latter recognized a sialic acid-containing ligand, present in all tissues, in addition to the A-like ligand of the digestive tract shared with the GI.1 strain. Furthermore, bioaccumulation experiments using wild-type or mutant GI.1 Viruslike particles showed accumulation in hemocytes largely, but not exclusively, based on interaction with the A-like ligand. Moreover, a seasonal effect on the expression of these ligands was detected, most visibly for the GI.1 strain, with a peak in late winter and spring, a period when GI strains are regularly involved in oyster-related outbreaks. These observations may explain some of the distinct epidemiological features of strains from different genogroups.
INTRODUCTION

1
Bivalve molluscan shellfish, such as oysters, can filter large volumes of water as part of their 2 feeding activities and are able to accumulate and concentrate different types of pathogens from fecal 3 human pollution. We have known for 40 years that bacteria and viruses show differences in terms of 4 concentration, accumulation and depuration from contaminated shellfish (34) . As a consequence, 5 absence of virus contamination cannot reliably be deduced from failure to detect bacterial 6 contamination. A better understanding of the virus-specific modes of shellfish contamination is 7 needed. A number of factors, including water temperature, mucus production, glycogen content of 8 connective tissue or gonadal development have been identified to influence enterovirus and phage bio-9 accumulation in oysters (7, 13) .
10
Among human enteric viruses, noroviruses (NoVs) are recognized as being the leading cause of 11 epidemics or sporadic cases of gastroenteritis in all age groups of humans (15) . They are discharged in 12 large amounts in sewage and, being very resistant to inactivation, they have been detected in 13 wastewater treatment plant effluents and in surface waters (44) . The sanitary consequences are 14 contamination of drinking water and foods such as shellfish, leading to outbreaks among consumers 15 (57) . Improved understanding of norovirus behavior in shellfish may lead to increased sanitary quality outbreaks indicate that binding to these carbohydrates is required for infection (20, 25, 27, 49) .
23
Moreover, various human NoV strains that bind to HBGAs present distinct specificities for HBGAs.
24
As a result, most strains infect only a subset of the population based on HBGAs expression (26, 51) . It 
25
was proposed that NoVs carbohydrate binding properties could be used to improve detection in waters 26 and other complex samples (9) .
27
We previously demonstrated specific binding of the Norwalk virus strain to the oyster digestive 28 tract through an A-like carbohydrate structure indistinguishable from human blood group A antigen 29 (23) . Subsequently, this observation was confirmed in different oyster species and for other NoV 30 strains (52, 54) . Human A blood group antigen is one of the HBGA ligands of NoVs that are involved 31 in the infection process (26, 48) , suggesting that oysters may have the ability to specifically 32 accumulate and concentrate a human pathogen based on the presence of a shared ligand between the 33 two species rather than through non-specific interactions only. Since, different NoV strains show 34 different specificities for HBGAs in humans, all strains may not be captured equally well by oysters.
35
This new concept where the relationship between the shellfish carbohydrate ligands and the 36 virus strain specificity is taken into account may be used as a tool to discriminate within different 
21
(NeuAcα2,3Galβ4GlcNAcβ3Galβ4Glcβ-R).
22
Constructs containing open reading frames 2 and 3 were used to produce recombinant VLPs for 23 genogroup I.1 (Norwalk virus, strain 8FIIa, Genbank accession number M87661.1) and genogroup II. 4 
24
(Houston strain, Genbank accession number EU310927) as previously described (6) . Mutants in the 25 P2 subdomain of VP1 were generated by Ala point substitution and used to produce recombinant
26
VLPs His 329 (H329A), Asn 331 (N331A), and Trp 375 (W375A) (11) . After purification, the protein 27 concentrations were determined and the number of VLPs was calculated based upon the VP1 28 molecular weight and 180 copies of VP1 per virus particle (18, 39) . Corresponding antibodies were 29 produced by immunizing rabbits with the GI.1 or the GII.4 purified VLPs, respectively.
30
Oyster samples. A large batch of oysters (Crassostrea gigas) was purchased at the beginning 31 of the study and placed in a clean area in Brittany. These oysters were used for ELISA assay, immuno-32 histochemistry and bioaccumulation experiments. All samples, each including at least eight oysters
33
were then randomly collected from this batch and shipped within 24 hours to the laboratory at 4°C.
34
Environmental data such as water temperature and salinity were monitored on a daily basis using a
35
Marel smatch TPS (NKE, Hennebont, France), located exactly on the same point as the oysters. 
10
Immunohistochemical analysis. Oysters (uncontaminated or after bioaccumulation) were 11 shucked and the body was cut horizontally so as to visualize all organs (from the mouth to the anus)
12
on a single section. Sections were fixed in 10% formaldehyde (Gurr, VWR, France) for 24 hours,
13
paraffin embedded, and sliced into thin sections (5 µm). After preparation of tissue sections as 14 described previously (32) , sections from uncontaminated oysters were covered with 2 µg GI.1 or GII. 4 
15
VLPs/ml (10 11 particles/ml) of and left overnight at 4°C before being washed three times for 5 min in
16
PBS at room temperature. The presence of VLPs bound to the oyster tissue was detected using 17 respective antibodies as previously described (32) . Negative controls included sections from 18 uncontaminated samples not exposed to VLPs, and exposed sections without primary antibody.
19
Staining with MAA was performed by incubating sections with the biotinylated lectin diluted at 10 20 µg/ml overnight at 4°C, followed by a second incubation with peroxidase-labeled avidin at 1/1000 for 21 45 min at room tmperature. Immunoreactivity, detected under microscopic analysis, was considered as 22 strong (intense red coloration), weak (pale red coloration) or negative (no coloration).
23
For bioaccumulation experiments, brightfield images captured with an Olympus color CCD camera 24 were analysed using a deconvolution algorithm to separate the dye contribution at each pixel (41).
25
Regions of interest (covering hemocytes surfaces) were selected for each image through a markup 26 algorithm in Image-J.
27
Neuraminidase treatment was performed on oyster sections by incubation at 37°C with 15 mU 
5
Comparison of the genogroups binding capacity to oysters tissue extracts. By using 6
representative VLPs GI.1 and GII.4, the two main human NoV genogroups were compared in their 7 capacity to bind to different oyster tissues, namely the digestive tissue, the gills and the mantle (Table   8 1). GI.1 VLPs bound readily to digestive tissues but not to the gills or the mantle. With GI.1 VLP, the 9 mutants H329A and W375A lost their capacity to bind to digestive tissues whereas the N331A mutant 10 bound to digestive tissues. The ratio observed for this mutant was slightly higher than for the GI.1
11 prototype for all tissues tested, but the differences were not significant ( 
15
In a previous study we demonstrated on tissues sections that GI. 
30
Identification of the VLP ligands.
31
In order to get insights into the structure of the second carbohydrate ligand of GII. 4 VLPs, we 32 first tested the binding of the two strains to a selected set of neoglycoconjugates (Fig. 2) (Fig. 3A) . No binding was observed to gills, mantle or labial 6 palps ( Fig. 3A and C) . The GII.4 VLPs also bound to the different digestive organs, but strong binding 7 was additionally observed to labial palps, gills and mantle (Fig. 3B, D 
30
VLPs was largely decreased (Fig. 3M and N) . In contrast, no effect was observed on GI.1 VLPs 31 binding (Fig. 3O ).
32
Bioaccumulation. In order to evaluate biological impact of live oysters, bioaccumulations were 33 performed using the different GI.1 VLPs, using final concentrations ranging from 5x10 5 to 5x10 8 
34
VLPs/ml of seawater. GI. contamination by sewage of a producing area few years ago, we found that after one week the number 12 of shellfish containing GII NoVs was higher than for GI strains, whereas after three weeks the will be important to evaluate viral particle behavior.
5
Another major interest of the data presented here concerns the observed seasonal variation.
6
Oysters are able to bind much more efficiently to GI.1 VLPs during the first five months of the year 7 (January to May) as compared to the rest of the year. At variance with our results, a lack of seasonal 8 variation was reported for three oyster species using GI. 
